Index -
P/E -
EPS (ttm) -0.13
Insider Own 13.52%
Shs Outstand 21.15M
Perf Week -0.62%
Market Cap 82.92M
Forward P/E -
EPS next Y -0.04
Insider Trans 0.43%
Shs Float 17.82M
Perf Month 14.35%
Income -2.57M
PEG -
EPS next Q -0.06
Inst Own 58.22%
Short Float 10.92%
Perf Quarter 2.68%
Sales 270.77M
P/S 0.31
EPS this Y 122.97%
Inst Trans -23.34%
Short Ratio 8.86
Perf Half Y -2.54%
Book/sh 4.54
P/B 0.89
EPS next Y -152.94%
ROA -1.54%
Short Interest 1.95M
Perf Year -60.03%
Cash/sh 2.23
P/C 1.80
EPS next 5Y -0.02%
ROE -2.43%
52W Range 2.90 - 10.53
Perf YTD -46.76%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -2.73%
52W High -61.78%
Beta 0.70
Dividend TTM -
Quick Ratio 0.89
Sales past 5Y 0.18%
Gross Margin 24.74%
52W Low 38.79%
ATR (14) 0.19
Dividend Ex-Date Aug 11, 2023
Current Ratio 1.33
EPS Y/Y TTM 24.79%
Oper. Margin -0.35%
RSI (14) 57.53
Volatility 4.75% 5.14%
Employees 287
Debt/Eq 0.01
Sales Y/Y TTM 2.21%
Profit Margin -0.95%
Recom 4.00
Target Price 3.50
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 511.24%
Payout -
Rel Volume 0.64
Prev Close 4.10
Sales Surprise -9.40%
EPS Surprise 300.00%
Sales Q/Q -13.15%
Earnings Aug 06 AMC
Avg Volume 219.70K
Price 4.03
SMA20 2.80%
SMA50 13.08%
SMA200 -8.63%
Trades
Volume 21,134
Change -1.83%
Date
Action
Analyst
Rating Change
Price Target Change
May-25-23 Initiated
Lake Street
Buy
$20
Jan-20-22 Upgrade
Sidoti
Neutral → Buy
$32
Nov-18-21 Initiated
Morgan Stanley
Underweight
$25
Oct-01-21 Initiated
Jefferies
Hold
$28
Aug-05-21 Resumed
Credit Suisse
Underperform
$22
Jun-03-21 Downgrade
Sidoti
Buy → Neutral
$39
Mar-05-21 Upgrade
Sidoti
Neutral → Buy
Jan-27-21 Downgrade
Sidoti
Buy → Neutral
Aug-19-20 Upgrade
Sidoti
Neutral → Buy
$37 → $41
Apr-09-20 Downgrade
Sidoti
Buy → Neutral
Mar-12-20 Upgrade
Sidoti
Neutral → Buy
$31
Feb-24-20 Downgrade
Sidoti
Buy → Neutral
Aug-16-19 Upgrade
Craig Hallum
Sell → Hold
Aug-16-19 Downgrade
Craig Hallum
Buy → Hold
Jun-15-18 Initiated
CL King
Neutral
Aug-24-17 Upgrade
Sidoti
Neutral → Buy
Jul-24-17 Upgrade
Northcoast
Neutral → Buy
May-09-16 Upgrade
Craig Hallum
Sell → Hold
Feb-04-16 Initiated
Credit Suisse
Underperform
Jul-19-10 Reiterated
JMP Securities
Mkt Outperform
$23 → $21
Show Previous Ratings
Oct-09-24 09:50AM
Sep-27-24 04:17PM
Sep-23-24 09:50AM
Sep-12-24 08:00AM
Aug-21-24 08:30AM
12:45PM
Loading…
Aug-07-24 12:45PM
(Thomson Reuters StreetEvents) -14.36%
Aug-06-24 05:41PM
(Associated Press Finance)
04:05PM
Aug-05-24 04:05PM
Jul-23-24 08:00AM
Jun-27-24 01:36PM
01:36PM
Jun-24-24 08:00AM
Jun-16-24 07:00AM
Jun-12-24 08:02AM
03:52AM
Loading…
03:52AM
Jun-11-24 08:53PM
04:25PM
(Associated Press Finance)
04:05PM
Jun-03-24 08:00AM
May-28-24 08:00AM
May-22-24 04:05PM
May-20-24 08:00AM
Apr-30-24 08:34AM
Apr-29-24 10:25AM
08:15AM
Apr-15-24 12:52PM
08:26AM
(Associated Press Finance)
08:16AM
Apr-04-24 01:45PM
03:44AM
Loading…
Mar-18-24 03:44AM
Mar-13-24 08:17AM
Feb-28-24 06:00PM
Feb-22-24 04:21AM
Feb-16-24 08:30AM
Feb-15-24 01:34PM
08:30AM
Feb-14-24 01:47AM
Feb-09-24 09:26AM
06:05AM
(Thomson Reuters StreetEvents)
Feb-08-24 04:56PM
04:01PM
Jan-29-24 08:30AM
Jan-08-24 05:46PM
Dec-19-23 06:36PM
Dec-16-23 07:00AM
Dec-08-23 04:35PM
Dec-07-23 02:56PM
Nov-27-23 12:26PM
Nov-13-23 10:40AM
Nov-06-23 04:50PM
Oct-31-23 08:28AM
08:10AM
05:26AM
(Thomson Reuters StreetEvents)
Oct-30-23 05:56PM
04:43PM
(Associated Press Finance)
04:01PM
Oct-19-23 08:30AM
Oct-12-23 06:20PM
Oct-11-23 01:18PM
Sep-19-23 09:00AM
Sep-07-23 04:01PM
07:30AM
Aug-06-23 08:05AM
Aug-04-23 06:04AM
Aug-01-23 07:09AM
(Thomson Reuters StreetEvents) -5.87%
Jul-31-23 04:21PM
04:01PM
Jul-19-23 06:05AM
Jul-18-23 09:09AM
Jul-17-23 08:30AM
Jul-12-23 06:51AM
Jul-07-23 08:40AM
Jul-04-23 10:24AM
Jul-03-23 09:49PM
Jun-23-23 09:07AM
Jun-02-23 06:46PM
Jun-01-23 08:30AM
May-30-23 06:45AM
May-23-23 06:48AM
(Thomson Reuters StreetEvents)
May-22-23 06:04PM
04:20PM
04:01PM
May-18-23 04:01PM
10:00AM
May-08-23 04:01PM
Apr-26-23 08:00PM
Apr-18-23 07:23AM
Apr-17-23 09:19PM
Apr-03-23 09:00AM
Mar-28-23 11:25AM
Mar-22-23 07:44PM
Mar-20-23 02:00PM
Mar-03-23 11:40AM
Feb-24-23 06:34AM
Feb-10-23 06:11PM
05:28AM
Feb-08-23 02:08PM
Feb-06-23 05:04PM
(Yahoo Finance Video) -7.11%
04:01PM
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, and generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
NINA CAPITAL HOLDINGS INC. 10% Owner Sep 09 '24 Buy 3.34 12,500 41,750 2,078,000 Oct 18 08:18 PM Smith Jacqueline Paula Vice President of People Aug 15 '24 Sale 3.19 601 1,917 20,099 Aug 19 05:05 PM FULGONI GIAN Director Nov 09 '23 Buy 7.34 41,000 301,124 109,510 Nov 13 11:52 AM Hulett Mathew N CEO & President Nov 03 '23 Buy 7.26 13,850 100,551 613,850 Nov 07 02:17 PM Chambers Christine CFO Nov 03 '23 Buy 7.26 6,888 50,007 19,888 Nov 07 02:10 PM
Index -
P/E -
EPS (ttm) -
Insider Own 87.21%
Shs Outstand 62.09M
Perf Week 0.39%
Market Cap 1.12B
Forward P/E -
EPS next Y -
Insider Trans 0.09%
Shs Float 7.94M
Perf Month -
Income -
PEG -
EPS next Q 0.19
Inst Own 1.67%
Short Float 1.02%
Perf Quarter -
Sales -
P/S -
EPS this Y -
Inst Trans -
Short Ratio 0.26
Perf Half Y -
Book/sh 0.29
P/B 61.30
EPS next Y -
ROA -
Short Interest 0.08M
Perf Year -
Cash/sh 0.02
P/C 726.13
EPS next 5Y -
ROE -
52W Range 14.16 - 20.10
Perf YTD 12.56%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -
52W High -10.40%
Beta -
Dividend TTM -
Quick Ratio 0.66
Sales past 5Y 14.93%
Gross Margin -
52W Low 27.19%
ATR (14) 1.24
Dividend Ex-Date -
Current Ratio 0.90
EPS Y/Y TTM -
Oper. Margin -
RSI (14) -
Volatility 4.44% -
Employees -
Debt/Eq 4.25
Sales Y/Y TTM -
Profit Margin -
Recom 1.33
Target Price 21.33
Option/Short No / Yes
LT Debt/Eq 3.06
EPS Q/Q -
Payout -
Rel Volume 0.13
Prev Close 18.01
Sales Surprise -
EPS Surprise -
Sales Q/Q -
Earnings Aug 28
Avg Volume 311.05K
Price 18.01
SMA20 3.22%
SMA50 3.22%
SMA200 3.22%
Trades
Volume 6,250
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-21-24 Initiated
Truist
Buy
$22
Oct-21-24 Initiated
Raymond James
Outperform
$21
Oct-21-24 02:54PM
Oct-08-24 09:02AM
Sep-26-24 10:50AM
Sep-25-24 09:45PM
09:10PM
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Salentine Thomas J Jr Director Sep 27 '24 Buy 14.00 35,714 499,996 35,714 Oct 01 05:48 PM Patchett Mary Sue Director Sep 27 '24 Buy 14.00 3,571 49,994 3,571 Oct 01 05:46 PM LEWIS RANDALL J Director Sep 27 '24 Buy 14.00 3,571 49,994 3,571 Oct 01 05:43 PM COSLER STEVEN D Director Sep 27 '24 Buy 14.00 7,142 99,988 7,142 Oct 01 05:43 PM
Index RUT
P/E -
EPS (ttm) -0.95
Insider Own 69.06%
Shs Outstand 171.19M
Perf Week 0.95%
Market Cap 2.75B
Forward P/E 21.48
EPS next Y 0.75
Insider Trans 10.88%
Shs Float 53.05M
Perf Month 5.19%
Income -163.04M
PEG -
EPS next Q 0.15
Inst Own 46.55%
Short Float 12.54%
Perf Quarter 32.42%
Sales 9.94B
P/S 0.28
EPS this Y 142.63%
Inst Trans 32.86%
Short Ratio 5.20
Perf Half Y 48.52%
Book/sh 9.33
P/B 1.72
EPS next Y 33.45%
ROA -2.95%
Short Interest 6.65M
Perf Year -
Cash/sh 0.15
P/C 109.67
EPS next 5Y 6.00%
ROE -13.88%
52W Range 7.85 - 16.49
Perf YTD 45.55%
Dividend Est. -
P/FCF -
EPS past 5Y 10.47%
ROI -3.72%
52W High -2.91%
Beta -
Dividend TTM -
Quick Ratio 1.00
Sales past 5Y 30.27%
Gross Margin 14.95%
52W Low 103.95%
ATR (14) 0.51
Dividend Ex-Date -
Current Ratio 1.33
EPS Y/Y TTM -69.42%
Oper. Margin 2.01%
RSI (14) 69.32
Volatility 3.18% 3.58%
Employees 600
Debt/Eq 1.82
Sales Y/Y TTM 21.98%
Profit Margin -1.64%
Recom 1.17
Target Price 17.14
Option/Short Yes / Yes
LT Debt/Eq 1.74
EPS Q/Q 398.71%
Payout -
Rel Volume 0.19
Prev Close 16.11
Sales Surprise 4.47%
EPS Surprise -25.87%
Sales Q/Q 26.01%
Earnings Nov 01 BMO
Avg Volume 1.28M
Price 16.01
SMA20 4.86%
SMA50 13.84%
SMA200 37.40%
Trades
Volume 35,574
Change -0.62%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-11-24 Initiated
KeyBanc Capital Markets
Sector Weight
Jun-21-24 Initiated
BTIG Research
Buy
$15
Mar-06-24 Initiated
HSBC Securities
Buy
$13
Feb-27-24 Upgrade
Deutsche Bank
Hold → Buy
$11.50
Feb-20-24 Initiated
Wells Fargo
Overweight
$15
Feb-20-24 Initiated
UBS
Buy
$15
Feb-20-24 Initiated
Morgan Stanley
Overweight
$18
Feb-20-24 Initiated
Leerink Partners
Outperform
$15
Feb-20-24 Initiated
Jefferies
Buy
$18
Feb-20-24 Initiated
Guggenheim
Buy
$15
Feb-20-24 Initiated
Goldman
Buy
$26
Feb-20-24 Initiated
Deutsche Bank
Hold
$11.50
Feb-20-24 Initiated
BofA Securities
Buy
$14
Show Previous Ratings
Oct-12-24 05:48PM
Oct-07-24 03:03PM
Oct-01-24 04:05PM
Sep-30-24 07:30AM
Sep-14-24 02:17AM
04:00PM
Loading…
Sep-13-24 04:00PM
Sep-12-24 11:17AM
Sep-03-24 04:30PM
Aug-26-24 09:00PM
Aug-22-24 04:05PM
Aug-02-24 06:00AM
Jul-08-24 07:30AM
Jul-02-24 04:05PM
Jun-24-24 04:55PM
Jun-06-24 04:35PM
07:30AM
Loading…
Jun-03-24 07:30AM
May-22-24 04:05PM
07:30AM
May-20-24 07:30AM
May-08-24 09:55AM
May-05-24 08:14AM
May-03-24 03:24AM
May-02-24 10:57AM
06:00AM
Apr-26-24 05:09PM
Apr-10-24 04:35PM
Apr-09-24 04:05PM
Apr-04-24 07:30AM
Mar-26-24 07:30AM
Mar-21-24 07:30AM
04:35PM
Loading…
Mar-20-24 04:35PM
Mar-14-24 04:45PM
Mar-01-24 08:42AM
Feb-29-24 06:30AM
Feb-15-24 04:35PM
Jan-26-24 04:50PM
04:20PM
(The Wall Street Journal)
04:05PM
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM KKR Group Partnership L.P. 10% Owner Sep 11 '24 Buy 11.13 11,619,998 129,330,578 92,959,984 Sep 13 04:44 PM KKR Phoenix Aggregator L.P. 10% Owner Sep 11 '24 Buy 11.13 11,619,998 129,330,578 92,959,984 Sep 13 04:36 PM DAmbrosio Matthew Director May 20 '24 Buy 11.46 1,000 11,461 1,000 May 21 06:17 PM Yowler Jennifer President, PharMerica Mar 15 '24 Buy 8.21 3,000 24,630 60,880 Mar 18 03:27 PM Mattingly James F Jr See Remarks Mar 15 '24 Buy 8.26 6,080 50,221 134,780 Mar 18 03:27 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 369,763 Mar 18 03:26 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 1,025,636 Mar 18 03:26 PM Phipps Jennifer A Chief Accounting Officer Mar 14 '24 Buy 8.14 12,300 100,122 165,618 Mar 15 05:34 PM Mattingly James F Jr See Remarks Mar 14 '24 Buy 8.18 12,280 100,450 128,700 Mar 15 05:34 PM ROUSSEAU JON B See Remarks Mar 14 '24 Buy 8.12 37,405 303,729 39,352 Mar 15 05:33 PM
Index S&P 500
P/E 25.47
EPS (ttm) 9.21
Insider Own 10.47%
Shs Outstand 200.81M
Perf Week -0.82%
Market Cap 46.23B
Forward P/E 15.87
EPS next Y 14.79
Insider Trans -23.68%
Shs Float 176.42M
Perf Month 4.12%
Income 1.86B
PEG 2.55
EPS next Q 3.22
Inst Own 89.47%
Short Float 5.81%
Perf Quarter 3.31%
Sales 283.83B
P/S 0.16
EPS this Y 13.77%
Inst Trans 0.89%
Short Ratio 6.76
Perf Half Y -1.40%
Book/sh 4.70
P/B 49.96
EPS next Y 8.40%
ROA 2.90%
Short Interest 10.24M
Perf Year 24.26%
Cash/sh 17.31
P/C 13.56
EPS next 5Y 10.00%
ROE 230.42%
52W Range 182.75 - 247.66
Perf YTD 14.24%
Dividend Est. 2.00 (0.85%)
P/FCF 12.07
EPS past 5Y 2.53%
ROI 36.46%
52W High -5.26%
Beta 0.44
Dividend TTM 2.04 (0.87%)
Quick Ratio 0.55
Sales past 5Y 9.95%
Gross Margin 2.96%
52W Low 28.39%
ATR (14) 3.73
Dividend Ex-Date Aug 09, 2024
Current Ratio 0.89
EPS Y/Y TTM 12.06%
Oper. Margin 1.00%
RSI (14) 59.39
Volatility 1.52% 1.50%
Employees 46000
Debt/Eq 5.11
Sales Y/Y TTM 11.56%
Profit Margin 0.65%
Recom 1.95
Target Price 260.80
Option/Short Yes / Yes
LT Debt/Eq 4.50
EPS Q/Q 2.99%
Payout 22.74%
Rel Volume 0.33
Prev Close 234.17
Sales Surprise 1.26%
EPS Surprise 3.82%
Sales Q/Q 10.90%
Earnings Nov 06 BMO
Avg Volume 1.51M
Price 234.62
SMA20 3.36%
SMA50 1.04%
SMA200 1.38%
Trades
Volume 75,606
Change 0.19%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-18-24 Downgrade
BofA Securities
Buy → Neutral
$275 → $245
Feb-26-24 Initiated
Leerink Partners
Outperform
$261
Jan-03-24 Initiated
Barclays
Overweight
$242
Dec-14-23 Initiated
Wells Fargo
Equal Weight
$213
Mar-31-23 Initiated
Citigroup
Buy
$185
Jan-31-23 Resumed
Evercore ISI
Outperform
$185
Oct-11-22 Upgrade
BofA Securities
Neutral → Buy
$160 → $169
Aug-22-22 Resumed
Morgan Stanley
Equal-Weight
Jul-11-22 Downgrade
Evercore ISI
Outperform → In-line
$150
Jun-07-22 Upgrade
Deutsche Bank
Hold → Buy
$167 → $178
May-26-22 Upgrade
Barclays
Equal Weight → Overweight
Apr-12-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$178
Apr-01-22 Resumed
Credit Suisse
Outperform
$180
Feb-04-21 Upgrade
Evercore ISI
In-line → Outperform
Jan-06-21 Upgrade
BofA Securities
Underperform → Neutral
Jun-15-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$112
Apr-23-20 Resumed
Credit Suisse
Outperform
$105
Apr-01-20 Upgrade
JP Morgan
Neutral → Overweight
$93 → $106
Feb-07-20 Upgrade
Robert W. Baird
Neutral → Outperform
$112
Sep-12-19 Initiated
Deutsche Bank
Hold
Show Previous Ratings
Oct-21-24 09:40AM
Oct-15-24 12:10PM
Oct-11-24 09:45AM
Oct-01-24 07:30AM
Sep-27-24 07:00AM
(The Wall Street Journal)
07:10PM
Loading…
Sep-18-24 07:10PM
12:37PM
Aug-30-24 09:40AM
Aug-22-24 09:45AM
Aug-15-24 07:30AM
Aug-14-24 09:40AM
Aug-05-24 05:48PM
Aug-02-24 12:51PM
12:00PM
11:51AM
06:17PM
Loading…
Aug-01-24 06:17PM
06:08PM
Jul-31-24 04:44PM
06:30AM
Jul-30-24 09:50AM
Jul-29-24 09:40AM
Jul-25-24 08:30AM
Jul-12-24 09:40AM
Jul-11-24 12:10PM
07:00AM
Jul-08-24 08:35AM
Jul-05-24 04:15PM
Jul-03-24 03:50PM
Jun-28-24 08:03AM
07:52AM
07:44AM
Loading…
Jun-26-24 07:44AM
Jun-25-24 07:30AM
Jun-24-24 08:28AM
Jun-17-24 11:34AM
Jun-10-24 09:40AM
Jun-02-24 04:00PM
May-31-24 11:31AM
May-27-24 07:42AM
May-24-24 02:00PM
May-23-24 09:40AM
May-22-24 05:44PM
05:38PM
May-15-24 05:17PM
May-02-24 01:00PM
May-01-24 10:00PM
04:24PM
08:44AM
07:40AM
06:30AM
Apr-26-24 09:15AM
07:29AM
Apr-15-24 09:40AM
07:48AM
Apr-12-24 09:45AM
Apr-05-24 08:30AM
Apr-04-24 09:15AM
Apr-01-24 12:38PM
Mar-29-24 09:40AM
04:27AM
Mar-28-24 10:03AM
Mar-27-24 09:45AM
07:19AM
Mar-19-24 09:48AM
09:15AM
Mar-13-24 09:40AM
Mar-12-24 08:30AM
Mar-08-24 03:13AM
Mar-05-24 02:56AM
Feb-28-24 12:00PM
Feb-27-24 09:15AM
Feb-14-24 04:18PM
(The Wall Street Journal)
Feb-08-24 08:19PM
09:15AM
Feb-07-24 07:33PM
06:26PM
06:16PM
01:11PM
09:45AM
09:40AM
Feb-05-24 06:18PM
Feb-04-24 07:50AM
Feb-01-24 09:30AM
Jan-31-24 07:11PM
(Morningstar Research) +5.51%
10:14AM
07:40AM
06:30AM
Jan-30-24 12:10PM
Jan-29-24 08:23AM
Jan-26-24 09:15AM
Jan-22-24 09:15AM
Jan-04-24 04:30PM
Jan-03-24 09:15AM
Nov-22-23 09:40AM
09:15AM
09:00AM
Nov-09-23 08:16PM
06:58PM
06:49PM
Nov-06-23 05:36PM
09:40AM
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
COLLIS STEVEN H Officer Oct 22 '24 Proposed Sale 235.80 21,509 5,071,822 Oct 22 10:43 AM COLLIS STEVEN H Chairman, President & CEO Sep 17 '24 Option Exercise 89.58 21,509 1,926,776 306,597 Sep 18 04:37 PM COLLIS STEVEN H Chairman, President & CEO Sep 17 '24 Sale 241.01 21,509 5,183,884 285,088 Sep 18 04:37 PM Lon Greenberg Other: Board Sep 17 '24 Proposed Sale 239.88 4,000 959,520 Sep 17 05:27 PM COLLIS STEVEN H Officer Sep 17 '24 Proposed Sale 241.01 21,509 5,183,884 Sep 17 09:36 AM COLLIS STEVEN H Chairman, President & CEO Aug 20 '24 Option Exercise 89.58 10,754 963,343 295,842 Aug 21 04:08 PM COLLIS STEVEN H Chairman, President & CEO Aug 20 '24 Sale 239.13 10,754 2,571,604 285,088 Aug 21 04:08 PM COLLIS STEVEN H Officer Aug 20 '24 Proposed Sale 239.13 10,754 2,571,604 Aug 20 10:47 AM Battaglia Silvana Executive Vice President Aug 06 '24 Sale 242.69 1,473 357,482 10,948 Aug 07 04:09 PM Battaglia Silvana Officer Aug 06 '24 Proposed Sale 242.69 1,473 357,483 Aug 06 02:08 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM COLLIS STEVEN H Chairman, President & CEO Jul 16 '24 Option Exercise 89.58 10,755 963,433 295,843 Jul 17 04:09 PM COLLIS STEVEN H Chairman, President & CEO Jul 16 '24 Sale 222.12 10,755 2,388,901 285,088 Jul 17 04:09 PM Donato Leslie E EVP & Chief Strategy Officer Jul 01 '24 Option Exercise 0.00 1,432 0 9,991 Jul 02 04:08 PM COLLIS STEVEN H Chairman, President & CEO Jun 18 '24 Option Exercise 89.58 10,754 963,343 295,842 Jun 20 04:16 PM COLLIS STEVEN H Chairman, President & CEO Jun 18 '24 Sale 235.76 10,754 2,535,363 285,088 Jun 20 04:16 PM Clark Gina Executive Vice President May 31 '24 Sale 223.86 1,874 419,506 13,284 Jun 03 04:05 PM Clark Gina Executive Vice President May 29 '24 Option Exercise 86.09 27,093 2,332,436 42,251 May 31 04:00 PM Clark Gina Executive Vice President May 29 '24 Sale 216.07 27,093 5,853,985 15,158 May 31 04:00 PM Clark Gina Executive Vice President Mar 18 '24 Sale 238.12 9,644 2,296,429 15,158 May 31 04:00 PM DURCAN DERMOT MARK Director May 24 '24 Buy 218.58 500 109,290 21,876 May 29 04:02 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM COLLIS STEVEN H Chairman, President & CEO May 21 '24 Option Exercise 89.58 10,755 963,433 295,843 May 22 04:08 PM COLLIS STEVEN H Chairman, President & CEO May 21 '24 Sale 221.30 10,755 2,380,082 285,088 May 22 04:08 PM Mauch Robert P. Executive Vice President & COO Apr 15 '24 Option Exercise 89.58 33,877 3,034,702 81,976 Apr 17 04:24 PM Mauch Robert P. Executive Vice President & COO Apr 15 '24 Sale 235.09 57,564 13,532,721 24,412 Apr 17 04:24 PM COLLIS STEVEN H Chairman, President & CEO Apr 16 '24 Option Exercise 89.58 10,754 963,343 295,842 Apr 17 04:23 PM COLLIS STEVEN H Chairman, President & CEO Apr 16 '24 Sale 237.48 10,754 2,553,860 285,088 Apr 17 04:23 PM COLLIS STEVEN H Chairman, President & CEO Mar 19 '24 Option Exercise 89.58 10,755 963,433 295,843 Mar 21 04:05 PM COLLIS STEVEN H Chairman, President & CEO Mar 19 '24 Sale 240.21 10,755 2,583,459 285,088 Mar 21 04:05 PM Campbell Elizabeth S Executive Vice President Mar 18 '24 Sale 238.12 6,977 1,661,363 8,246 Mar 20 04:23 PM Clark Gina Executive Vice President Feb 13 '24 Sale 230.48 1,100 253,528 24,802 Feb 14 04:14 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 07 '24 Sale 235.41 4,212,395 991,639,907 26,277,561 Feb 09 07:00 AM GREENBERG LON R Director Jan 15 '24 Option Exercise 219.43 1,340 294,036 26,219 Jan 17 04:04 PM Donato Leslie E EVP & Chief Strategy Officer Dec 21 '23 Sale 202.13 3,400 687,242 8,519 Dec 26 04:00 PM COLLIS STEVEN H Chairman, President & CEO Dec 13 '23 Sale 203.18 42,885 8,713,374 288,688 Dec 15 04:22 PM Campbell Elizabeth S Executive Vice President Dec 13 '23 Option Exercise 89.58 5,162 462,412 20,328 Dec 15 04:21 PM Campbell Elizabeth S Executive Vice President Dec 13 '23 Sale 203.13 5,162 1,048,578 15,166 Dec 15 04:21 PM Clark Gina Executive Vice President Dec 13 '23 Option Exercise 0.00 137 0 26,039 Dec 15 04:16 PM COLLIS STEVEN H Chairman, President & CEO Dec 12 '23 Option Exercise 77.53 25,000 1,938,250 356,573 Dec 13 04:10 PM COLLIS STEVEN H Chairman, President & CEO Dec 12 '23 Sale 202.15 25,000 5,053,750 331,573 Dec 13 04:10 PM Krikorian Lazarus SVP & Chief Accounting Officer Dec 01 '23 Sale 203.60 2,000 407,204 19,876 Dec 04 04:06 PM Battaglia Silvana Executive Vice President Nov 16 '23 Option Exercise 86.09 4,516 388,782 16,144 Nov 17 04:22 PM Battaglia Silvana Executive Vice President Nov 16 '23 Sale 196.00 14,747 2,890,412 11,628 Nov 17 04:22 PM COLLIS STEVEN H Chairman, President & CEO Nov 14 '23 Option Exercise 77.53 25,000 1,938,250 356,573 Nov 15 06:13 PM COLLIS STEVEN H Chairman, President & CEO Nov 14 '23 Sale 197.63 25,000 4,940,750 331,573 Nov 15 06:13 PM Cleary James F Chief Financial Officer Nov 13 '23 Option Exercise 77.53 38,136 2,956,684 139,762 Nov 15 06:12 PM Donato Leslie E EVP & Chief Strategy Officer Nov 13 '23 Option Exercise 86.09 3,387 291,587 15,306 Nov 15 06:10 PM Donato Leslie E EVP & Chief Strategy Officer Nov 13 '23 Sale 197.60 3,387 669,271 11,919 Nov 15 06:10 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 09 '23 Sale 195.38 1,279,590 249,999,896 30,489,956 Nov 14 07:15 AM
Index S&P 500
P/E 10.13
EPS (ttm) 5.62
Insider Own 0.21%
Shs Outstand 1.29B
Perf Week -12.43%
Market Cap 71.63B
Forward P/E 7.86
EPS next Y 7.24
Insider Trans 0.39%
Shs Float 1.26B
Perf Month -1.96%
Income 7.19B
PEG 2.72
EPS next Q 1.58
Inst Own 82.72%
Short Float 1.57%
Perf Quarter -2.92%
Sales 363.65B
P/S 0.20
EPS this Y -25.82%
Inst Trans 2.41%
Short Ratio 1.90
Perf Half Y -15.98%
Book/sh 59.66
P/B 0.95
EPS next Y 11.70%
ROA 2.86%
Short Interest 19.75M
Perf Year -17.47%
Cash/sh 12.97
P/C 4.39
EPS next 5Y 3.73%
ROE 9.74%
52W Range 52.77 - 83.25
Perf YTD -27.89%
Dividend Est. 2.53 (4.44%)
P/FCF 13.58
EPS past 5Y -
ROI 4.70%
52W High -31.60%
Beta 0.53
Dividend TTM 2.66 (4.67%)
Quick Ratio 0.66
Sales past 5Y 13.36%
Gross Margin 14.79%
52W Low 7.90%
ATR (14) 1.94
Dividend Ex-Date Oct 21, 2024
Current Ratio 0.86
EPS Y/Y TTM 144.48%
Oper. Margin 3.67%
RSI (14) 33.74
Volatility 3.05% 2.62%
Employees 300000
Debt/Eq 1.12
Sales Y/Y TTM 7.10%
Profit Margin 1.98%
Recom 1.93
Target Price 67.91
Option/Short Yes / Yes
LT Debt/Eq 1.04
EPS Q/Q -4.82%
Payout 38.34%
Rel Volume 1.25
Prev Close 56.85
Sales Surprise -0.19%
EPS Surprise 5.31%
Sales Q/Q 2.59%
Earnings Nov 06 BMO
Avg Volume 10.41M
Price 56.94
SMA20 -9.52%
SMA50 -4.88%
SMA200 -12.44%
Trades
Volume 1,945,751
Change 0.16%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-10-24 Upgrade
Barclays
Equal Weight → Overweight
$63 → $82
Oct-04-24 Upgrade
TD Cowen
Hold → Buy
$59 → $85
May-30-24 Initiated
Robert W. Baird
Neutral
$61
May-07-24 Downgrade
TD Cowen
Buy → Hold
$99 → $59
May-02-24 Downgrade
UBS
Buy → Neutral
$85 → $60
May-01-24 Downgrade
Leerink Partners
Outperform → Market Perform
$87 → $60
May-01-24 Downgrade
Cantor Fitzgerald
Overweight → Neutral
Mar-06-24 Initiated
Barclays
Equal Weight
$78
Feb-26-24 Initiated
Leerink Partners
Outperform
$88
Dec-22-23 Initiated
HSBC Securities
Buy
$94
Sep-19-23 Upgrade
Evercore ISI
In-line → Outperform
$81 → $83
Sep-12-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$80
Aug-18-23 Downgrade
Edward Jones
Buy → Hold
May-26-23 Initiated
Piper Sandler
Overweight
$85
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$87
Jan-03-23 Downgrade
Evercore ISI
Outperform → In-line
$120 → $100
Nov-23-22 Resumed
Morgan Stanley
Overweight
$124 → $119
Jun-17-22 Initiated
Loop Capital
Buy
$120
May-27-22 Downgrade
Bernstein
Outperform → Mkt Perform
$122 → $112
Mar-29-22 Downgrade
Deutsche Bank
Buy → Hold
$110
Show Previous Ratings
Today 07:00AM
Oct-22-24 02:05PM
12:41PM
10:54AM
10:15AM
03:56PM
Loading…
Oct-21-24 03:56PM
09:30AM
09:00AM
07:34AM
06:42AM
06:19AM
06:03AM
05:48AM
Oct-19-24 09:18PM
(Associated Press Finance)
07:17AM
07:00AM
Loading…
07:00AM
(The Wall Street Journal)
05:00AM
04:00AM
Oct-18-24 05:59PM
05:31PM
(The Wall Street Journal)
04:55PM
03:58PM
03:57PM
03:09PM
03:01PM
02:46PM
02:37PM
01:59PM
(The Wall Street Journal)
01:14PM
12:26PM
12:15PM
Loading…
12:15PM
11:28AM
11:25AM
10:44AM
10:44AM
10:17AM
10:06AM
09:55AM
09:29AM
09:15AM
08:50AM
08:24AM
08:05AM
08:03AM
(The Wall Street Journal)
07:50AM
07:14AM
07:11AM
(Associated Press Finance)
07:08AM
07:06AM
06:51AM
06:30AM
06:28AM
Oct-17-24 03:04PM
(The Wall Street Journal)
04:45AM
Oct-16-24 07:30AM
Oct-15-24 01:04PM
11:32AM
(The Wall Street Journal)
10:27AM
(The Wall Street Journal)
07:30AM
06:13AM
Oct-13-24 10:00AM
Oct-12-24 07:41AM
Oct-11-24 03:21PM
12:45PM
12:07PM
11:02AM
10:14AM
08:47AM
06:27AM
Oct-10-24 07:00PM
05:45PM
02:41PM
01:21PM
10:29AM
10:19AM
09:08AM
05:39AM
Oct-09-24 11:25AM
(The Wall Street Journal)
10:55AM
10:45AM
09:00AM
03:00AM
Oct-08-24 09:00AM
Oct-07-24 09:00AM
06:00AM
Oct-06-24 12:46PM
07:45AM
Oct-05-24 11:09AM
Oct-04-24 04:40PM
01:37PM
01:07PM
10:35AM
07:09AM
06:53AM
06:33AM
05:00AM
Oct-03-24 05:45PM
03:56PM
03:27PM
11:00AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LUDWIG EDWARD J Director May 02 '24 Buy 53.88 1,000 53,879 21,630 May 02 04:31 PM Mahoney Michael F Director May 02 '24 Buy 54.49 9,181 500,294 9,356 May 02 04:30 PM Shah Prem S EVP and Pres-Pharm, Consumer W Feb 16 '24 Sale 76.95 29,473 2,267,947 39,765 Feb 16 06:46 PM LUDWIG EDWARD J Director Nov 03 '23 Buy 70.47 2,000 140,930 20,630 Nov 06 10:59 AM
Index S&P 500
P/E -
EPS (ttm) -10.01
Insider Own 17.56%
Shs Outstand 864.00M
Perf Week -14.81%
Market Cap 8.15B
Forward P/E 6.13
EPS next Y 1.54
Insider Trans 0.00%
Shs Float 712.78M
Perf Month 10.55%
Income -8636.00M
PEG -
EPS next Q 0.40
Inst Own 61.89%
Short Float 13.28%
Perf Quarter -18.07%
Sales 147.66B
P/S 0.06
EPS this Y -42.64%
Inst Trans 2.25%
Short Ratio 4.63
Perf Half Y -47.05%
Book/sh 12.09
P/B 0.78
EPS next Y -6.91%
ROA -9.72%
Short Interest 94.65M
Perf Year -57.06%
Cash/sh 3.60
P/C 2.62
EPS next 5Y -
ROE -56.69%
52W Range 8.22 - 27.05
Perf YTD -63.88%
Dividend Est. 1.12 (11.83% )
P/FCF -
EPS past 5Y -
ROI -21.41%
52W High -65.14%
Beta 0.68
Dividend TTM 1.23 (13.04% )
Quick Ratio 0.37
Sales past 5Y 1.77%
Gross Margin 16.30%
52W Low 14.72%
ATR (14) 0.52
Dividend Ex-Date Aug 21, 2024
Current Ratio 0.68
EPS Y/Y TTM -180.71%
Oper. Margin 1.20%
RSI (14) 48.41
Volatility 6.78% 4.91%
Employees 312000
Debt/Eq 3.24
Sales Y/Y TTM 6.17%
Profit Margin -5.85%
Recom 3.11
Target Price 10.17
Option/Short Yes / Yes
LT Debt/Eq 2.86
EPS Q/Q -1570.28%
Payout -
Rel Volume 2.23
Prev Close 9.73
Sales Surprise 4.59%
EPS Surprise 8.64%
Sales Q/Q 6.00%
Earnings Oct 15 BMO
Avg Volume 20.45M
Price 9.43
SMA20 0.33%
SMA50 0.32%
SMA200 -39.49%
Trades
Volume 6,837,568
Change -3.08%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade
HSBC Securities
Hold → Reduce
Jan-03-24 Initiated
Barclays
Underweight
$21
Dec-22-23 Initiated
HSBC Securities
Hold
$27
Oct-23-23 Upgrade
JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated
Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade
Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade
Deutsche Bank
Sell → Hold
$51 → $43
Show Previous Ratings
Today 03:09AM
Oct-22-24 08:49PM
(Supermarket News) -6.89%
05:31PM
05:22PM
04:40PM
04:04PM
Loading…
04:04PM
02:56PM
12:41PM
12:31PM
10:54AM
10:15AM
04:50AM
04:15AM
Oct-21-24 05:49AM
Oct-20-24 05:00AM
06:45AM
Loading…
Oct-19-24 06:45AM
06:12AM
03:02AM
02:37AM
(Thomson Reuters StreetEvents)
Oct-18-24 03:05PM
12:44PM
08:15AM
05:00AM
04:00AM
02:00AM
Oct-17-24 04:45AM
03:00AM
Oct-16-24 04:50PM
10:27AM
07:05AM
06:00AM
Loading…
06:00AM
05:00AM
03:01AM
12:45AM
(Thomson Reuters StreetEvents)
Oct-15-24 06:06PM
05:50PM
05:29PM
04:15PM
(Investor's Business Daily)
04:06PM
03:26PM
03:25PM
02:21PM
02:08PM
01:30PM
01:04PM
12:45PM
12:24PM
11:51AM
11:50AM
11:45AM
11:23AM
10:55AM
10:46AM
10:40AM
10:40AM
10:37AM
10:30AM
(The Wall Street Journal)
10:14AM
10:09AM
09:55AM
09:42AM
09:36AM
09:30AM
08:58AM
08:57AM
08:10AM
07:22AM
(Associated Press Finance)
07:21AM
(Associated Press Finance)
07:17AM
(Associated Press Finance)
07:04AM
(The Wall Street Journal)
07:02AM
07:00AM
Oct-14-24 05:15PM
04:23PM
Oct-13-24 11:09AM
09:05AM
06:00AM
Oct-12-24 08:10AM
Oct-10-24 09:15AM
07:53AM
Oct-09-24 03:43PM
10:55AM
Oct-08-24 01:11PM
10:00AM
05:31AM
Oct-07-24 05:50PM
01:43PM
10:23AM
08:51AM
08:00AM
05:03AM
Oct-02-24 01:00PM
10:00AM
Oct-01-24 02:13PM
11:48AM
11:00AM
(Investor's Business Daily)
Sep-30-24 05:50PM
Sep-27-24 05:10AM
Sep-26-24 03:24PM
06:00AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 07 '24 Sale 235.41 4,212,395 991,639,907 26,277,561 Feb 09 07:00 AM JARRETT VALERIE B Director Jan 29 '24 Buy 22.44 4,456 99,993 4,456 Jan 31 04:11 PM SCHLICHTING NANCY M Director Jan 16 '24 Sale 23.05 15,209 350,567 0 Jan 18 04:18 PM WENTWORTH TIMOTHY C Chief Executive Officer Jan 05 '24 Buy 24.22 10,000 242,220 585,122 Jan 08 07:29 AM Gates Richard P. SVP, Chief Pharmacy Officer Nov 10 '23 Sale 20.45 1,000 20,450 73,929 Nov 14 08:22 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 09 '23 Sale 195.38 1,279,590 249,999,896 30,489,956 Nov 14 07:15 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite